Concurrent onabotulinumtoxina treatment of cervical dystonia and concomitant migraine
Headache: The Journal of Head and Face Pain,  Clinical Article

Winner PK et al. – Concurrent treatment with onabotulinumtoxinA is effective and well tolerated in controlling the symptoms of cervical dystonia complicated by concurrent migraine.

Methods
  • An open–label pilot study was conducted for 7.5 months in patients at least 18 years old with primary cervical dystonia of moderate severity (baseline rating of at least 20 on the Toronto Western Spasmodic Torticollis Rating Scale) complicated by migraine headache meeting the International Classification of Headache Disorders–II criteria for migraines with or without aura.
  • Each patient received 2 cycles of treatment at Visit 3 (baseline) and Visit 6 (Day 90).
  • For cervical dystonia, each patient was injected with a maximum of 175 units.
  • At the same visit, a maximum of 125 units was also injected for migraine using a fixed–site, fixed–dose injection paradigm, with additional cervical dystonia injection–site treatment to a maximum dose of 300 units.
  • Patients were assessed following onabotulinumtoxinA injection and at follow–up on Visit 4 (Day 30), Visit 5 (Day 60), Visit 6 (Day 90), and at Visits 7, 8, and 9 (Days 120, 150, and 180).
  • The primary outcome measures for this study were change in Toronto Western Spasmodic Torticollis Rating Scale total score for cervical dystonia and frequency of headache episodes per 28–day period.
  • Migraine episodes were defined as at least 4 hours of sustained pain with no upper limit.
  • An episode was considered new if the patient was pain free for at least 24 hours.
  • Secondary study end points included number of headache days per month, headache intensity, headache disability (assessed using Headache Impact Test–6 and the Migraine Disability Assessment score scales), acute headache medication use, resource utilization, and allodynia pain.
  • Adverse events were reported.

Results
  • A total of 25 patients (24 women, mean age 50.5 years; mean age of disease onset 21.9 years) were enrolled in the study.
  • Patients experienced improvement in cervical dystonia symptoms with significant reductions from baseline in Toronto Western Spasmodic Torticollis Rating Scale scores at 30, 60, 90, 120, 150, and 180 days (–9.84 ± 8.49, –12.67 ± 8.22, –13.63 ± 7.27, –14.92 ± 7.05, –4.76 ± 6.97, –14.49 ± 6.14, respectively, P < .0001 at all time points from a baseline of 31.03 ± 3.61).
  • Changes from baseline were assessed using the t–test.
  • Reductions in the number of headache episodes from baseline on concurrent onabotulinumtoxinA treatment for coexistent chronic migraine did not attain significance.
  • However, patients experienced significant reductions from baseline in the number of headache days at 90, 120, and 180 days (–3.39 ± 6.78, P = .0289; –4.29 ± 7.94, P = .0194; –4.38 ± 7.99, P = .0178, respectively, from a baseline of 15.33 ± 6.76).
  • Changes from baseline were assessed using the t–test.
  • The change from baseline in Headache Impact Test–6 total scores was significant at 30, 60, 90, 150, and 180 days (3.21 ± 4.14, P = .0009; –3.04 ± 4.04, P = .0012; –2.41 ± 2.79, P = .0006; –2.59 ± 3.87, P = .0050; –3.09 ± 3.80, respectively, from a baseline of 22.68 ± 3.20).
  • Changes from baseline were assessed using the t–test.
  • The change from baseline in Migraine Disability Assessment was significant at 120, 150, and 180 days (–38.09 ± 47.87, P < .0001, Wilcoxon signed rank test; –16.91 ± 62.69, P = .0358, Wilcoxon signed rank test; ?23.73 ± 40.57, P = .0122, t–test, respectively, from a baseline of 56.68 ± 50.41).
  • There were no serious adverse events or treatment–related disc

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Internal Medicine

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Internal Medicine Articles

1 Effects of tea intake on blood pressure: A meta-analysis of 21 randomized controlled trials JACC - Journal of the American College of Cardiology, October 22, 2014    Clinical Article

2 Cost-effectiveness of CT screening in the national lung screening trial New England Journal of Medicine, November 7, 2014    Evidence Based Medicine    Clinical Article
Exclusive Author Commentary

3 Effects of hyperbaric oxygen on symptoms and quality of life among service members with persistent postconcussion symptoms: a randomized clinical trial JAMA Internal Medicine, November 21, 2014    Evidence Based Medicine    Clinical Article

4 Sweetened carbonated beverage consumption and cancer risk: Meta-analysis and review European Journal of Cancer Prevention, August 1, 2014    Evidence Based Medicine    Review Article

5 The burden of disease in older people and implications for health policy and practice The Lancet, November 12, 2014    Evidence Based Medicine    Clinical Article

6 How World War 1 changed global attitudes to war and infectious diseases The Lancet, November 10, 2014    Evidence Based Medicine    Clinical Article

7 The causal effect of vitamin D binding protein (DBP) levels on calcemic and cardiometabolic diseases: a Mendelian randomization study Full Text PLoS Medicine, November 4, 2014    Free full text    Evidence Based Medicine    Clinical Article

8 Efficacy of a tetravalent dengue vaccine in children in Latin America New England Journal of Medicine, November 6, 2014    Evidence Based Medicine    Clinical Article

9 Sodium zirconium cyclosilicate in hyperkalemia New England Journal of Medicine, November 26, 2014    Evidence Based Medicine    Clinical Article

10 Changes in patients' experiences in medicare accountable care organizations New England Journal of Medicine, November 3, 2014    Evidence Based Medicine    Clinical Article

11 Milk intake and risk of mortality and fractures in women and men: cohort studies BMJ, November 11, 2014    Evidence Based Medicine    Clinical Article

12 Acupuncture for chronic knee pain: a randomized clinical trial JAMA, October 1, 2014    Evidence Based Medicine    Clinical Article

13 Nonobstructive coronary artery disease and risk of myocardial infarction JAMA, November 6, 2014    Evidence Based Medicine    Clinical Article

14 Evaluation and treatment of older patients with hypercholesterolemia: A clinical review JAMA, October 20, 2014    Clinical Article

15 Effects of vaccination on invasive pneumococcal disease in South Africa New England Journal of Medicine, November 19, 2014    Evidence Based Medicine    Clinical Article

16 Three-year denosumab treatment in postmenopausal Japanese women and men with osteoporosis: Results from a 1-year open-label extension of the Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT) Osteoporosis International, November 25, 2014    Evidence Based Medicine    Clinical Article

17 An interferon-free antiviral regimen for HCV after liver transplantation New England Journal of Medicine, November 13, 2014    Evidence Based Medicine    Clinical Article

18 Aspirin in type 2 diabetes, a randomised controlled study: effect of different doses on inflammation, oxidative stress, insulin resistance and endothelial function International Journal of Clinical Practice, December 27, 2013    Clinical Article

19 Non-psychotic mental disorders in the perinatal period The Lancet, November 20, 2014    Evidence Based Medicine    Clinical Article

20 Oral contraceptive use and mortality after 36 years of follow-up in the Nurses' Health Study: prospective cohort study BMJ, November 7, 2014    Evidence Based Medicine    Clinical Article

Indexed Journals in Internal Medicine: New England Journal of Medicine, The Lancet, Archives of Internal Medicinemore